TrueBlue, Inc. (TBI)
NYSE: TBI · Real-Time Price · USD
8.24
-0.34 (-3.91%)
Jul 21, 2026, 3:27 PM EDT - Market open

TrueBlue Earnings Call Transcripts

Fiscal Year 2026

  • The company is leveraging proprietary technology, targeted sales strategies, and expansion into high-growth sectors like energy and healthcare to drive top-line growth and margin expansion. Strong financial performance, a robust balance sheet, and a focus on innovation and operational efficiency support continued momentum.

  • AGM 2026

    The meeting covered board elections, executive compensation, incentive plan amendments, and auditor ratification, with all proposals approved by a strong majority. No shareholder questions were raised during the session.

  • Q1 2026 saw 8% revenue growth, led by energy and skilled verticals, with disciplined cost management and digital innovation offsetting margin pressures. Outlook remains positive with expected revenue and margin expansion, supported by strong sales momentum and strategic partnerships.

Fiscal Year 2025

  • Q4 revenue rose 8% year-over-year, led by skilled business and energy sector growth, while gross margin declined due to less favorable workers' comp adjustments and revenue mix. Cost discipline improved profitability, and the outlook anticipates continued revenue growth and margin recovery as market conditions stabilize.

  • Third-quarter revenue rose 13% year-over-year to $431 million, led by strong growth in skilled, energy, and healthcare staffing. Operational efficiencies drove margin expansion despite a lower gross margin, and the outlook calls for continued revenue growth and strategic investment in high-potential markets.

  • Q2 revenue was flat at $396M, with double-digit growth in skilled businesses and strong momentum in healthcare and energy. Cost reductions and digital innovation drove margin improvements, and Q3 is expected to return to company-wide growth with 5%-11% revenue increase.

  • Revenue declined 8% year-over-year to $370 million, with softness across most verticals but growth in commercial drivers and new business wins in high-value roles. Cost controls improved margins in some segments, and digital investments are supporting operational efficiency. Q2 revenue is expected to range from -1% to +5% year-over-year, with continued focus on healthcare and technology.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021